Skip to main content

Table 1 The demographic and clinical characteristics in the thoracotomy and VATS group

From: Video assisted thoracic surgery vs. thoracotomy for locally advanced lung squamous cell carcinoma after neoadjuvant chemotherapy

Variables

Thoracotomy (N = 67)

VATS (N = 14)

P value

Male gender

63 (94.0%)

11 (78.6%)

0.177

Age (year)

60 (29–77)

61 (55–73)

0.182

Smoking

59 (88.1%)

11 (78.6%)

0.608

Drinking

29 (43.3%)

5 (35.7%)

0.602

BMI

23 (17–30)

23 (18–29)

1

Weight loss

15 (22.4%)

2 (14.3%)

0.752

Hypertension

12 (17.9%)

6 (42.9%)

0.091

Diabetes

5 (7.5%)

1 (7.1%)

1

COPD

1 (1.5%)

0 (0)

1

Lymphocyte (10^9/L)

1.5 (0.8–4.0)

1.6 (0.7–3.2)

0.954

Total protein (g/L)

68.8 (54.4–82.4)

67.3 (39.2–80.6)

0.077

Albumin (g/L)

41.6 (26.6–54.8)

39.2 (20.9–50.9)

0.128

Serum Creatinine (mmol/L)

69.0 (52.0–105.0)

68.5 (50.0–119.0)

0.507

Serum trioxypurine (mmol/L)

296.5 (192.0–455.0)

319.5 (157.0–462.0)

0.676

Triglyceride (mmol/L)

1.1 (0.4–4.1)

1.2 (0.7–3.0)

0.581

Cholesterol (mmol/L)

4.2 (2.7–6.1)

4.3 (2.7–8.0)

0.399

  1. Values are N (percentage) or median (range)
  2. BMI body mass index, COPD chronic obstructive pulmonary disease, VATS video assisted thoracic surgery